1
|
Zhao D, Suo LD, Pan JB, Peng XH, Wang YF, Zhou T, Li XM, Ma Y, Li ZA, Pang XH, Lu L. [A follow-up study on the pain changes trend and effects in patients diagnosed with herpes zoster in Beijing City]. Zhonghua Yu Fang Yi Xue Za Zhi 2023; 57:2068-2072. [PMID: 38186158 DOI: 10.3760/cma.j.cn112150-20230607-00447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2024]
Abstract
Objective: To understand the changes in pain and its effects in patients with the diagnosis of herpes zoster. Methods: A total of 3 487 patients diagnosed with herpes zoster (HZ) for the first time at the outpatient department of Miyun District Hospital from January 1, 2017, to December 31, 2019, were included in the study. The information of patients was registered and issued with a record card. Patients were required to record the time of pain and rash by themselves. Telephone follow-up was conducted at 21, 90, 180 and 365 days after the onset of rashes, including hospitalization, location of rash and pain, and the time of start and end. The impact of pain on life was evaluated by the Zoster Brief Pain Inventory (ZBPI). Results: The age of 2 999 HZ patients included in the analysis were (53±16) years old, including 1 377 (45.91%) males and 1 903 (63.45%) patients aged 50 years and older. After 21 days of rash, mild, moderate and severe pain accounted for 20.87% (626 cases), 37.98% (1 139 cases) and 33.81% (1 014 cases), respectively. Only 5.07% (152 cases) had no pain or discomfort, and 2.27% (68 cases) had no pain but discomfort. Most of the pain sites were consistent with the rash sites. The chest and back and waist and abdomen were the most common, accounting for 35.58% (1 067 cases) and 29.18% (875 cases), respectively, followed by the limbs and face and neck, accounting for 16.74% (502 cases) and 16.40% (492 cases), respectively. The M (Q1, Q3) of pain days in the HZ patients was 14 (8, 20) days, and the incidence of post-herpetic neuralgia (PHN) was 6.63% (171/2 580) (excluding 419 patients who refused to visit or lost to visit on 90 days after the onset of rash). The pain score of HZ patients within 21 days after the rash was (5.19±2.73) points, and the pain score of PHN patients was (7.61±2.13) points, which was significantly higher than that of non-PHN patients [(5.04±2.69) points] (P<0.001). Daily activities, emotions, walking ability, work, social interaction, sleep and recreation were affected for 21 days after the rash in HZ patients, ranging from 60.79% to 83.83%, with sleep being the most affected (83.83%). The impact scores of pain and life dimensions in PHN patients ranged from 4.59 to 7.61 points on the ZBPI scale, which were higher than those in non-PHN patients (2.49-5.04) (t values ranged from 8.86 to 11.67, all P values <0.001). Conclusion: The proportion of pain in HZ patients after the diagnosis is high, and the pain is more obvious in patients with PHN and HZ patients aged 50 and older, which has a greater impact on their daily lives.
Collapse
Affiliation(s)
- D Zhao
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - L D Suo
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - J B Pan
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - X H Peng
- Miyun District Center for Disease Control and Prevention, Beijing 101500, China
| | - Y F Wang
- Miyun District Center for Disease Control and Prevention, Beijing 101500, China
| | - T Zhou
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - X M Li
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - Y Ma
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - Z A Li
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - X H Pang
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| | - L Lu
- Beijing Center for Disease Prevention and Control, Beijing 100013, China
| |
Collapse
|
2
|
Zhang ZJZ, Suo LD, Zhao D, Pan JB, Lu L. [Systematic reviews and evidence quality assessment on effectiveness of 1 dose varicella attenuated live vaccine for healthy children aged 1-12 years in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41:1138-1144. [PMID: 32741184 DOI: 10.3760/cma.j.cn112338-20191025-00762] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To assess the effectiveness of 1 dose varicella attenuated live vaccine (VarV) for healthy children aged 1-12 years in China and explore the application of the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) framework in observational studies of vaccine effectiveness (VE). Methods: We searched studies about the VE of 1-dose VarV for children aged 1-12 years in China which published before 2019 and evaluated the quality of the studies by the Newcastle Ottawa Scale (NOS) table. We used Meta-analysis models to obtain the pooled 1-dose VE and that in subgroups by study design, outbreak or not, study quality and age of subjects. The evidences of VEs were rated by means of the GRADE system. Results: Thirty-two studies were included and the pooled 1-dose VE was 75% [95% confidence interval (CI): 68%-80%]. The VE of outbreak studies [VE=66% (95%CI: 57%-73%)] was lower than non-outbreak studies [VE=85% (95%CI: 78%-89%)], and the VE in <6 years old children [VE=84% (95%CI:77%-89%)] was higher than that in ≥6 years old children [VE=60% (95%CI: 51%-68%)]. There was no significant difference in VE among studies with different design and quality. The quality of the evidences of pooled 1-dose VE was"very low", which was downgraded in bias risk and inconsistency and not downgraded in indirectness, imprecision and publication bias. Conclusions: The 1-dose VarV can provide medium level protection for 1-12 years old children in China, but it will decrease significantly for ≥6 years old children, so it is suggested to implement the strategies of two-dose vaccination of VarV in children <6 years old. The GRADE framework can be used in the observational studies of VE and it is suggested that the technical guidelines of observational study should be worked out to improve the overall quality of evidence.
Collapse
Affiliation(s)
- Z J Z Zhang
- Department of Immunization, Beijing Center for Diseases Prevention and Control, Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - L D Suo
- Department of Immunization, Beijing Center for Diseases Prevention and Control, Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - D Zhao
- Department of Immunization, Beijing Center for Diseases Prevention and Control, Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - J B Pan
- Department of Immunization, Beijing Center for Diseases Prevention and Control, Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - L Lu
- Department of Immunization, Beijing Center for Diseases Prevention and Control, Beijing Research Center for Preventive Medicine, Beijing 100013, China
| |
Collapse
|
3
|
Suo LD, Zhao D, Pan JB, Wang YC, Wang Q, Wang HH, Peng XH, Wang X, Zhu ZL, Wang YF, Pang XH, Lu L. [Analysis of herpes zoster incidence and hospitalization in three areas of Beijing in 2015 based on health information system of medical institutions]. Zhonghua Yu Fang Yi Xue Za Zhi 2019; 53:503-507. [PMID: 31091609 DOI: 10.3760/cma.j.issn.0253-9624.2019.05.013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: Using data of health information system (HIS) of medical institutions to study the incidence and hospitalization of herpes zoster in three districts of Beijing. Methods: According to the different level of economic development and geographical features in Beijing, 3 districts of Xicheng, Changping and Miyun were chosen and all 110 medical institutions of the first level and above in the 3 districts are included in the survey. All the outpatient and inpatient herpes zoster cases in 2015 were retrospectively reviewed by HIS system. After distinguishing the reduplicated cases, Using the first outpatient case as a molecule and the resident population as denominator to estimate the annual incidence rate, as well as the annual hospitalization rate was estimated based on primary diagnostic hospitalized cases as molecule and the resident population as denominator. Results: A total of 32 313 primary visit outpatient cases were investigated, of which 18 360 cases (56.8%) were women and 20 923 cases (64.8%) were ≥50 years old. The overall estimated incidence of the 3 districts was 8.8‰ with an increase trends with age and reached to the highest in ≥80 years old (30.5/1 000). The incidence of Xicheng, Changping and Miyun districts are respectively 16.2‰, 4.0‰ and 5.7‰. A total of 701 primary visit inpatient cases were identified, of which 366 cases (52.2%) were women and 651 cases (92.9%) were ≥50 years old. The estimated annual hospitalization rate was 19.4/100 000, with the primary and secondary diagnostic hospitalization rate are respectively 5.9/100 000 (212 cases) and 13.5/100 000 (489 cases). The disease types of secondary diagnostic inpatient herpes zoster cases were as follows: cardiovascular disease (19.0%, 93 cases), stroke (14.5%, 71 cases), pneumonia/chronic obstructive pulmonary disease (14.1%, 69 cases), tumor (12.5%, 61 cases) and diabetes (5.7%, 28 cases). Conclusion: Most of the herpes zoster cases in Beijing are over 50 years old, and the incidence of female is slightly higher than male. This disease should become a public health issue of great concern.
Collapse
Affiliation(s)
- L D Suo
- Institute of Immunization and Prevention, Beijing Municipal Center for Disease Prevention and Control/ Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - D Zhao
- Institute of Immunization and Prevention, Beijing Municipal Center for Disease Prevention and Control/ Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - J B Pan
- Institute of Immunization and Prevention, Beijing Municipal Center for Disease Prevention and Control/ Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - Y C Wang
- Beijing Municipal Health Commission, Disease Control Department, Beijing 100053, China
| | - Q Wang
- Institute of Immunization and Prevention, Beijing Xicheng District Center for Disease Control and Prevention, Beijing 100120, China
| | - H H Wang
- Institute of Immunization and Prevention, Beijing Changping District Center for Disease Control and Prevention, Beijing 100220, China
| | - X H Peng
- Institute of Immunization and Prevention, Beijing Miyun District Center for Disease Control and Prevention, Beijing 101500, China
| | - X Wang
- Institute of Immunization and Prevention, Beijing Xicheng District Center for Disease Control and Prevention, Beijing 100120, China
| | - Z L Zhu
- Institute of Immunization and Prevention, Beijing Changping District Center for Disease Control and Prevention, Beijing 100220, China
| | - Y F Wang
- Institute of Immunization and Prevention, Beijing Miyun District Center for Disease Control and Prevention, Beijing 101500, China
| | - X H Pang
- Institute of Immunization and Prevention, Beijing Municipal Center for Disease Prevention and Control/ Beijing Research Center for Preventive Medicine, Beijing 100013, China
| | - L Lu
- Institute of Immunization and Prevention, Beijing Municipal Center for Disease Prevention and Control/ Beijing Research Center for Preventive Medicine, Beijing 100013, China
| |
Collapse
|
4
|
Lin X, Lu JC, Shao Y, Zhang YY, Wu X, Pan JB, Gao L, Zhu SY, Qian K, Zhang YF, Bao DL, Li LF, Wang YQ, Liu ZL, Sun JT, Lei T, Liu C, Wang JO, Ibrahim K, Leonard DN, Zhou W, Guo HM, Wang YL, Du SX, Pantelides ST, Gao HJ. Intrinsically patterned two-dimensional materials for selective adsorption of molecules and nanoclusters. Nat Mater 2017; 16:717-721. [PMID: 28604716 DOI: 10.1038/nmat4915] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/05/2017] [Accepted: 05/03/2017] [Indexed: 06/07/2023]
Abstract
Two-dimensional (2D) materials have been studied extensively as monolayers, vertical or lateral heterostructures. To achieve functionalization, monolayers are often patterned using soft lithography and selectively decorated with molecules. Here we demonstrate the growth of a family of 2D materials that are intrinsically patterned. We demonstrate that a monolayer of PtSe2 can be grown on a Pt substrate in the form of a triangular pattern of alternating 1T and 1H phases. Moreover, we show that, in a monolayer of CuSe grown on a Cu substrate, strain relaxation leads to periodic patterns of triangular nanopores with uniform size. Adsorption of different species at preferred pattern sites is also achieved, demonstrating that these materials can serve as templates for selective self-assembly of molecules or nanoclusters, as well as for the functionalization of the same substrate with two different species.
Collapse
Affiliation(s)
- X Lin
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - J C Lu
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - Y Shao
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - Y Y Zhang
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
- Department of Physics and Astronomy and Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, Tennessee 37235, USA
| | - X Wu
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - J B Pan
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - L Gao
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - S Y Zhu
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - K Qian
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - Y F Zhang
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - D L Bao
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - L F Li
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - Y Q Wang
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - Z L Liu
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - J T Sun
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - T Lei
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - C Liu
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - J O Wang
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - K Ibrahim
- Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, China
| | - D N Leonard
- Material Sciences and Technology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37381, USA
| | - W Zhou
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
- Material Sciences and Technology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37381, USA
| | - H M Guo
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - Y L Wang
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - S X Du
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| | - S T Pantelides
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
- Department of Physics and Astronomy and Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, Tennessee 37235, USA
| | - H-J Gao
- Institute of Physics & University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100190, China
| |
Collapse
|
5
|
Lu M, Wang LF, Du XH, Yu YK, Pan JB, Nan ZJ, Han J, Wang WX, Zhang QZ, Sun QP. Molecular cloning and expression analysis of jasmonic acid dependent but salicylic acid independent LeWRKY1. Genet Mol Res 2015; 14:15390-8. [PMID: 26634504 DOI: 10.4238/2015.november.30.16] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Various plant genes can be activated or inhibited by phytohormones under conditions of biotic and abiotic stress, especially in response to jasmonic acid (JA) and salicylic acid (SA). Interactions between JA and SA may be synergistic or antagonistic, depending on the stress condition. In this study, we cloned a full-length cDNA (LeWRKY1, GenBank accession No. FJ654265) from Lycopersicon esculentum by rapid amplification of cDNA ends. Sequence analysis showed that this gene is a group II WRKY transcription factor. Analysis of LeWRKY1 mRNA expression in various tissues by qRT-PCR showed that the highest and lowest expression occurred in the leaves and stems, respectively. In addition, LeWRKY1 expression was induced by JA and Botrytis cinerea Pers., but not by SA.
Collapse
Affiliation(s)
- M Lu
- Plant Science and Technology College, Beijing University of Agriculture, Beijing, China
| | - L F Wang
- School of Life Sciences, Shandong Normal University, Jinan, China
| | - X H Du
- School of Life Sciences, Shandong Normal University, Jinan, China
| | - Y K Yu
- Center of Tissue Culture, Beijing University of Agriculture, Beijing, China
| | - J B Pan
- Plant Science and Technology College, Beijing University of Agriculture, Beijing, China
| | - Z J Nan
- Plant Science and Technology College, Beijing University of Agriculture, Beijing, China
| | - J Han
- Plant Science and Technology College, Beijing University of Agriculture, Beijing, China
| | - W X Wang
- Plant Science and Technology College, Beijing University of Agriculture, Beijing, China
| | - Q Z Zhang
- Plant Science and Technology College, Beijing University of Agriculture, Beijing, China
| | - Q P Sun
- Plant Science and Technology College, Beijing University of Agriculture, Beijing, China
| |
Collapse
|
6
|
Abstract
MicroRNAs (miRNAs) are a class of non-coding small RNAs that negatively regulate gene expression at the post-transcriptional level. Although thousands of miRNAs have been identified in plants, limited information is available about miRNAs in Phaseolus vulgaris, despite it being an important food legume worldwide. The high conservation of plant miRNAs enables the identification of new miRNAs in P. vulgaris by homology analysis. Here, 1804 known and unique plant miRNAs from 37 plant species were blast-searched against expressed sequence tag and genomic survey sequence databases to identify novel miRNAs in P. vulgaris. All candidate sequences were screened by a series of miRNA filtering criteria. Finally, we identified 27 conserved miRNAs, belonging to 24 miRNA families. When compared against known miRNAs in P. vulgaris, we found that 24 of the 27 miRNAs were newly discovered. Further, we identified 92 potential target genes with known functions for these novel miRNAs. Most of these target genes were predicted to be involved in plant development, signal transduction, metabolic pathways, disease resistance, and environmental stress response. The identification of the novel miRNAs in P. vulgaris is anticipated to provide baseline information for further research about the biological functions and evolution of miRNAs in P. vulgaris.
Collapse
Affiliation(s)
- J Han
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, China
| | - H Xie
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, China
| | - M L Kong
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, China
| | - Q P Sun
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, China
| | - R Z Li
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, China
| | - J B Pan
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, China
| |
Collapse
|
7
|
Han J, Kong ML, Xie H, Sun QP, Nan ZJ, Zhang QZ, Pan JB. Identification of miRNAs and their targets in wheat (Triticum aestivum L.) by EST analysis. Genet Mol Res 2013; 12:3793-805. [PMID: 24085441 DOI: 10.4238/2013.september.19.11] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
MicroRNAs (miRNAs) are a newly discovered class of noncoding small RNAs that regulate gene expression by directing target mRNA cleavage or translational inhibition. A large number of miRNAs have been identified in plants. Increasing evidence has shown that miRNAs play multiple roles in plant biological processes. So far, identification of miRNAs has been limited to a few model plant species, whose genomes have been sequenced. Wheat (Triticum aestivum L.) is one of the most important cereal crops worldwide. To date, only a few conserved miRNAs have been predicted in wheat. Here, we showed the conserved miRNAs identified in wheat by expressed sequence tag (EST) analysis. All previously known miRNAs from Arabidopsis, rice, and other plant species were used in a BLAST search against the wheat EST database to identify novel wheat miRNAs by a series of filtering criteria. By this strategy, we identified 62 conserved miRNAs, belonging to 30 miRNA families, 48 of which were newly discovered in wheat. These newly identified wheat miRNAs may regulate 287 potential targets, which are involved in development, signal transduction, metabolic pathways, disease resistance, ion transportation, and environmental stress response.
Collapse
Affiliation(s)
- J Han
- Beijing Key Laboratory for Agricultural Application and New Technique, College of Plant Science and Technology, Beijing University of Agriculture, Beijing, China
| | | | | | | | | | | | | |
Collapse
|
8
|
Pan JB, Takeshita T, Morimoto K. P300 as a measure of cognitive dysfunction from occupational and environmental insults. Environ Health Prev Med 2012; 4:103-10. [PMID: 21432181 DOI: 10.1007/bf02932264] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/1999] [Accepted: 12/26/1999] [Indexed: 10/21/2022] Open
Abstract
The P300 component of the event-related brain potential (ERP) is a sensitive, non-invasive, and convenient measure of cognitive dysfunction resulting from a variety of etiological agents. Application-orientated research on using the P300 measure as a cognitive probe for a wide range of neurological and psychiatric situations has been expanding rapidly in the last decade.The aim of this paper is to preview issues of application-oriented P300 research in occupational and environment medicine. Firstly, the neurophysiological background of the P300 is outlined. Secondly, the recent findings of P300 abnormalities following various occupational and environmental exposures are overviewed. Thirdly, the empirical issues for application-oriented research such as the potential causes of variability, limitation and difficulty are summarized, with suggestion for controlling them and for future standardization. Finally, it is concluded that P300 assessments demonstrate promising possibility as a sensitive marker for general cognitive dysfunction in occupational and environmental medicine.
Collapse
Affiliation(s)
- J B Pan
- Department of Social and Environmental Medicine Osaka University Graduate School of Medicine, Osaka
| | | | | |
Collapse
|
9
|
El-Kouhen O, Lehto SG, Pan JB, Chang R, Baker SJ, Zhong C, Hollingsworth PR, Mikusa JP, Cronin EA, Chu KL, McGaraughty SP, Uchic ME, Miller LN, Rodell NM, Patel M, Bhatia P, Mezler M, Kolasa T, Zheng GZ, Fox GB, Stewart AO, Decker MW, Moreland RB, Brioni JD, Honore P. Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist. Br J Pharmacol 2006; 149:761-74. [PMID: 17016515 PMCID: PMC2014656 DOI: 10.1038/sj.bjp.0706877] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND AND PURPOSE To further assess the clinical potential of the blockade of metabotropic glutamate receptors (mGluR1) for the treatment of pain. EXPERIMENTAL APPROACH We characterized the effects of A-841720, a novel, potent and non-competitive mGluR1 antagonist in models of pain and of motor and cognitive function. KEY RESULTS At recombinant human and native rat mGluR1 receptors, A-841720 inhibited agonist-induced calcium mobilization, with IC50 values of 10.7+/-3.9 and 1.0 +/- 0.2 nM, respectively, while showing selectivity over other mGluR receptors, in addition to other neurotransmitter receptors, ion channels, and transporters. Intraperitoneal injection of A-841720 potently reduced complete Freund's adjuvant-induced inflammatory pain (ED50 = 23 micromol kg(-1)) and monoiodoacetate-induced joint pain (ED50 = 43 micromol kg(-1)). A-841720 also decreased mechanical allodynia observed in both the sciatic nerve chronic constriction injury and L5-L6 spinal nerve ligation (SNL) models of neuropathic pain (ED50 = 28 and 27 micromol kg(-1), respectively). Electrophysiological studies demonstrated that systemic administration of A-841720 in SNL animals significantly reduced evoked firing in spinal wide dynamic range neurons. Significant motor side effects were observed at analgesic doses and A-841720 also impaired cognitive function in the Y-maze and the Water Maze tests. CONCLUSIONS AND IMPLICATIONS The analgesic effects of a selective mGluR1 receptor antagonist are associated with motor and cognitive side effects. The lack of separation between efficacy and side effects in pre-clinical models indicates that mGluR1 antagonism may not provide an adequate therapeutic window for the development of such antagonists as novel analgesic agents in humans.
Collapse
Affiliation(s)
- O El-Kouhen
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - S G Lehto
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - J B Pan
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - R Chang
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - S J Baker
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - C Zhong
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - P R Hollingsworth
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - J P Mikusa
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - E A Cronin
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - K L Chu
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - S P McGaraughty
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - M E Uchic
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - L N Miller
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - N M Rodell
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - M Patel
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - P Bhatia
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - M Mezler
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Ludwigshafen, Germany
| | - T Kolasa
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - G Z Zheng
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - G B Fox
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - A O Stewart
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - M W Decker
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - R B Moreland
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - J D Brioni
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
| | - P Honore
- Neuroscience Research, Global Pharmaceutical Research Division, Abbott Laboratories Abbott Park, IL, USA
- Author for correspondence:
| |
Collapse
|
10
|
Fox GB, Esbenshade TA, Pan JB, Browman KE, Zhang M, Ballard ME, Radek RJ, Miner H, Bitner RS, Krueger KM, Yao BB, Faghih R, Rueter LE, Komater VA, Drescher KU, Buckley MJ, Sullivan JP, Cowart MD, Decker MW, Hancock AA. 2. Histaminergic mechanisms in the CNS. Inflamm Res 2005; 54 Suppl 1:S23-4. [PMID: 15928819 DOI: 10.1007/s00011-004-0410-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Affiliation(s)
- G B Fox
- Neuroscience Research, Abbott Laboratories, AP9A, Global Pharmaceutical Research and Development, Abbott Park, Illinois 60064, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Cowart M, Faghih R, Gfesser G, Curtis M, Sun M, Zhao C, Bennani Y, Wetter J, Marsh K, Miller TR, Krueger K, Pan JB, Drescher K, Fox GB, Esbenshade TA, Hancock AA. Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonists. Inflamm Res 2005; 54 Suppl 1:S25-6. [PMID: 15928820 DOI: 10.1007/s00011-004-0411-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Affiliation(s)
- M Cowart
- Department R4MN, AP9A-216, Abbott Laboratories, Global Pharmaceutical Research and Development, 100 Abbott Park Road, Abbott Park, IL 60064-6123, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Fox GB, Pan JB, Lewis AM, Browman KE, Komater VA, Buckley MJ, Curzon P, Radek RJ, Faghih R, Esbenshade TA, Cowart MD, Decker MW, Hancock AA. Cognition enhancing effects of novel H 3 receptor (H 3 R) antagonists in several animal models. Inflamm Res 2004; 53 Suppl 1:S49-50. [PMID: 15054614 DOI: 10.1007/s00011-003-0323-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2003] [Accepted: 01/01/2003] [Indexed: 10/26/2022] Open
Affiliation(s)
- G B Fox
- Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Fox GB, Pan JB, Faghih R, Esbenshade TA, Lewis A, Bitner RS, Black LA, Bennani YL, Decker MW, Hancock AA. Identification of novel H3 receptor (H3R) antagonists with cognition enhancing properties in rats. Inflamm Res 2003; 52 Suppl 1:S31-2. [PMID: 12755398 DOI: 10.1007/s000110300041] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- G B Fox
- Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, AP9A, R4N5, 100 Abbott Park Rd., Abbott Park, Illinois 60064-6115, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
O'Neill AB, Pan JB, Sullivan JP, Brioni JD. Pharmacological evaluation of an in vivo model of vestibular dysfunction in the rat. Methods Find Exp Clin Pharmacol 1999; 21:285-9. [PMID: 10399137 DOI: 10.1358/mf.1999.21.4.538180] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
A unilateral microinjection of either histamine or kainic acid was made into the medial vestibular nucleus of rats, eliciting robust barrel rotations that were evaluated by an elevated body-rotation test. Systemic pretreatment with betahistine or GT-2016 significantly attenuated the kainic acid-induced barrel rotations. These data indicate that the animal model described herein may represent a new model to identify novel drugs with potential antivertigo properties.
Collapse
Affiliation(s)
- A B O'Neill
- Neurological and Urological Diseases Research (D4ND), Abbott Laboratories, Abbott Park, IL, USA
| | | | | | | |
Collapse
|
15
|
Pan JB, O'Neill AB, Hancock AA, Sullivan JP, Brioni JD. Histaminergic ligands attenuate barrel rotation in rats following unilateral labyrinthectomy. Methods Find Exp Clin Pharmacol 1998; 20:771-7. [PMID: 10022031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
In this paper we present a unilateral labyrinthectomy (UL) surgical procedure in rats that was derived from previous techniques. The utility of this model to assess vestibular dysfunction was evaluated by examining the ability of clinically used histaminergic agents and more selective H3 receptor antagonists to attenuate of UL-induced body rotations. Unilateral labyrinthectomy was performed by injection of ethanol into the rat right inner ear. An elevated body rotation test (EBRT) was used to assess the abnormal rotational behavior induced by UL. Scores of "3" to "0" were used to characterize the degree of abnormal behavior according to the latency of body rotations to begin. Our results demonstrate that: i) 100 microliters ethanol induced robust behavioral changes, which was used in further experiments; ii) the clinically used antivertigo agent, astemizole, significantly reduced the rotational behavior in UL rats; iii) the more potent H3 antagonists, thioperamide and GT-2016, were more efficacious than betahistine, a mixed H3 antagonist and H1 agonist. These results indicate that this model may be a potential tool for testing novel drugs for antivertigo effects and provide better support to the role of the histaminergic system in the control of vestibular function.
Collapse
Affiliation(s)
- J B Pan
- Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL, USA.
| | | | | | | | | |
Collapse
|
16
|
Metzger RE, LaDu MJ, Pan JB, Getz GS, Frail DE, Falduto MT. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J Neuropathol Exp Neurol 1996; 55:372-80. [PMID: 8786396 DOI: 10.1097/00005072-199603000-00013] [Citation(s) in RCA: 72] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Apolipoprotein E (apoE) is a plasma protein that regulates lipid transport and cholesterol homeostasis. In humans, apoE occurs as 3 major isoforms (apoE2, E3, and E4). Genetic evidence demonstrates an overrepresentation of the apoE epsilon 4 allele in Alzheimer's disease (AD). While apoE immunoreactivity (IR) is associated with the amyloid plaques and neurofibrillary tangles of AD, few studies have characterized the localization of apoE in normal human brains. We examined the distribution of apoE in the cerebral cortex of normal aged individuals and compared the results to clinically diagnosed and pathologically confirmed AD cases. In addition, we characterized the apoE IR in brains from high plaque non-demented (HPND) cases. We observed consistent and widespread apoE staining in cortical neurons from normal and HPND individuals. This finding was confirmed by double immunostaining which colocalized apoE with microtubule-associated protein-2, as well as low density lipoprotein receptor-related protein, an apoE receptor found on neurons. In contrast, AD brains displayed apoE IR in plaques and neurofibrillary tangles with little neuronal staining. These data clearly establish the presence of apoE in normal neurons, supporting an intracellular role for apoE. Moreover, the results suggest that this function of apoE is disrupted in AD, where apoE staining of neurons was drastically reduced.
Collapse
Affiliation(s)
- R E Metzger
- Neuroscience Discovery, Pharmaceutical Products Division, Abbott Laboratories, IL 60064, USA
| | | | | | | | | | | |
Collapse
|
17
|
Giordano T, Pan JB, Monteggia LM, Holzman TF, Snyder SW, Krafft G, Ghanbari H, Kowall NW. Similarities between beta amyloid peptides 1-40 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats. Exp Neurol 1994; 125:175-82. [PMID: 8313936 DOI: 10.1006/exnr.1994.1022] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Peptides corresponding to the first 40 amino acids of beta amyloid peptide (beta 1-40) and the reverse sequence (beta 40-1) were synthesized, purified, and compared for their ability to aggregate and cause toxicity in vitro to human neuroblastoma cells (SH-SY5Y), as well as for effects following injection into young or aged rats. Aggregation of both peptides produced similar sedimentation velocity profiles and resulted in significant toxicity in vitro with no observable differences between beta 1-40 and beta 40-1. In addition, when injected into the cortex of young rats, beta 1-40 was more toxic than beta 40-1 although both resulted in significant lesions. However, in aged rats the two peptides resulted in lesions of similar size. Alz 50 staining and abnormal neurites were associated with both beta 1-40 and beta 40-1 lesions; however, no evidence of plaques or tangles was found in either age group. While both peptides were toxic in vitro, only beta 1-40 elicited Alz 50 staining of SH-SY5Y cells. Electron microscopic examination of beta 1-40 and beta 40-1 aggregates showed that beta 1-40 formed fibrillar structures whereas beta 40-1 resulted in amorphous particles. Thus, although both peptides were toxic to cultured cells and aged rats, the toxicities may have resulted from different mechanisms.
Collapse
Affiliation(s)
- T Giordano
- Abbott Laboratories, Department of Neuroscience, Abbott Park, Illinois 60064
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Pan JB, Monteggia LM, Giordano T. Altered levels and splicing of the amyloid precursor protein in the adult rat hippocampus after treatment with DMSO or retinoic acid. Brain Res Mol Brain Res 1993; 18:259-66. [PMID: 7684485 DOI: 10.1016/0169-328x(93)90198-x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Alzheimer's disease and cognitive impairment in rats has been associated with an increase in the percentage of amyloid precursor protein (APP) containing the KPI domain. It has recently been reported that retinoic acid (RA) is capable of increasing the levels and altering the splicing ratio of APP in cultured SH-SY5Y cells. The effects of peripherally administered RA (64 or 640 micrograms/kg; i.p.; q.d.) on the abundance of APP, the ratio of the three major isoforms, and the relative abundance of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) were determined by rtPCR in the hippocampus of aged rats. Corresponding changes in choline acetyltransferase (ChAT) activity were also measured. Vehicle (DMSO) treated rats exhibited a 2 x (P < 0.01) increase in total APP and an 8 x (P < 0.001) decrease in the cyclophilin transcript. In addition, DMSO increased the percentage of APP 695 from 89% in saline treated rats to 94%. Treatment of RA in DMSO decreased the accumulation of total APP relative to cyclophilin at both the low (6.4 x; P < 0.01) and high (8 x; P < 0.05) dosages when compared to DMSO treated rats. Furthermore, the level of APP-695 decreased to 82% with low dosage of RA and 75% at high dosage of the total APP transcripts. No significant change in either NGF, NT-3, or BDNF transcripts were observed following low or high dosage RA administration relative to cyclophilin RNA nor was a change in ChAT activity detected at either of the dosages tested.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- J B Pan
- Abbott Laboratories, Abbott Park, IL 60064-3500
| | | | | |
Collapse
|
19
|
Giordano T, Pan JB, Casuto D, Watanabe S, Arneric SP. Thyroid hormone regulation of NGF, NT-3 and BDNF RNA in the adult rat brain. Brain Res Mol Brain Res 1992; 16:239-45. [PMID: 1337933 DOI: 10.1016/0169-328x(92)90231-y] [Citation(s) in RCA: 96] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
The effects of peripherally administered thyroid hormone (TH; 500 micrograms/kg; i.p.; q.d.) on the relative abundances of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-3 (NT-3) RNA were determined by rtPCR in the cortex and hippocampus of young adult rats. Corresponding changes in choline acetyltransferase (ChAT) activity were measured since NGF and BDNF have been shown to enhance the expression of this marker enzyme of central cholinergic pathways. Abundance levels of NGF and NT-3, relative to cyclophilin (cycl), were increased significantly (+50%, P < 0.05) in the hippocampus following TH treatment. Despite enhanced abundance of NGF in the hippocampus, ChAT activity was unchanged, whereas ChAT activity was modestly increased by 28% in the cortex without corresponding changes in NGF, NT-3 or BDNF. These results demonstrate that TH administration is capable of inducing the accumulation of NT-3, in addition to NGF but that the induction levels of RNA cannot be directly correlated with responsivity of the cholinergic system as measured by ChAT activity.
Collapse
Affiliation(s)
- T Giordano
- Abbott Laboratories, Neuroscience Research, Abbott Park, IL 60064-3500
| | | | | | | | | |
Collapse
|
20
|
Abstract
Levels of the endogenous excitotoxin quinolinic acid were measured in brain and lumbar spinal fluid from Alzheimer patients and age-matched controls. Values in post mortem brain tissue, unlike those in spinal fluid, showed considerable variability among subjects. In the control group, frontal cortex and caudate nucleus had higher concentrations of quinolinic acid compared to other regions studied. No significant differences were found between Alzheimer brains and controls in any of the regions analyzed. Studies in lumbar spinal fluid showed no gradient for quinolinic acid along the neuraxis, a trend for increasing levels with normal aging, and no difference between Alzheimer patients and age-matched control subjects. The lack of increased central quinolinic acid levels in Alzheimer's disease does not necessarily negate the possibility of excitotoxins contributing to cell death in this disorder.
Collapse
Affiliation(s)
- M M Mourdian
- Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892
| | | | | | | | | | | | | |
Collapse
|
21
|
Pan JB. [Mechanism of PLG (L-prolyl-L-leucyl-glycinamide) in treating Parkinson's disease]. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1985; 18:205-8. [PMID: 2866940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|